A short-term 2017 study, however, did not find that intranasal GSH produced better results than a placebo effect, which turned out to be quite high
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose Phase 1 trial
Schwartz, L
At his one-month follow-up appointment, reported home glucose monitoring revealed a fasting glucose value of 110-120 mg/dL, pre-lunch values of 120-130 mg/dL, pre-dinner values of 160-170 mg/dL, and bedtime values of 130-140 mg/dL
Same chemical structure, same plasma half-life (~5 days), same mechanism
Over time, functioning scores showed a notable improvement at 180 days postoperative ( = 3.13 [0.77